Phorbol ester activates CD5+ leukaemic B cells via a T cell‐independent mechanism
- 1 February 1995
- journal article
- Published by Wiley in Immunology & Cell Biology
- Vol. 73 (1) , 44-51
- https://doi.org/10.1038/icb.1995.7
Abstract
B cell chronic lymphocytic leukaemia (B-CLL) is characterized by the proliferation and accumulation of sIgM+ CD5+ lymphocytes that fail to progress to the final stages of B cell development. Stimulation of unfractionated PBL from three patients with B-CLL with the phorbol ester PMA and the mitogens PHA and PWM resulted in significant increases in cell proliferation, RNA synthesis and IgM secretion when compared to unstimulated cell populations. PMA was the most potent inducer of IgM secretion and this occurred irrespective of the presence of residual T cells. PMA-induced proliferation and RNA synthesis was also independent of T cells. However, in the presence of T cells, these parameters of cellular activation were enhanced during in vitro culture. Thus, the inductive ability of PMA on CD5+ CLL B cells was independent of T cells. In contrast, activation and differentiation of the malignant CD5+ B cells into IgM-secreting cells following culture with mitogens did not occur in the absence of T cells.Keywords
This publication has 20 references indexed in Scilit:
- Antiproliferative Effect of Interleukin-4 in B Chronic Lymphocytic LeukemiaJournal of Immunotherapy, 1991
- In vitroActivation of B-CLL CellsLeukemia & Lymphoma, 1991
- Possible immunoregulatory role for CD5+B cellsClinical Immunology and Immunopathology, 1990
- CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoireImmunology Today, 1989
- Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B‐type chronic lymphocytic leukemia cells depending on the costimulatory activation and progression signalsEuropean Journal of Immunology, 1989
- Probing the Human B-Cell Repertoire with EBV: Polyreactive Antibodies and CD5+ B LymphocytesAnnual Review of Immunology, 1989
- Effects of anti-IgM on mitogen-induced proliferation of human B-lymphocyte malignanciesClinical Immunology and Immunopathology, 1986
- Heterogeneity of responsiveness of chronic lymphocytic leukemic B cells to B cell growth factor or interleukin 2European Journal of Immunology, 1986
- Interleukin 2-induced proliferation of leukemic human B cells.The Journal of Experimental Medicine, 1985
- Phorbol ester-induced differentiation of chronic lymphocytic leukaemia cellsNature, 1980